NO975992L - Compounds with growth hormone releasing properties - Google Patents
Compounds with growth hormone releasing propertiesInfo
- Publication number
- NO975992L NO975992L NO975992A NO975992A NO975992L NO 975992 L NO975992 L NO 975992L NO 975992 A NO975992 A NO 975992A NO 975992 A NO975992 A NO 975992A NO 975992 L NO975992 L NO 975992L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- growth hormone
- hormone releasing
- releasing properties
- properties
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 230000003578 releasing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK71995 | 1995-06-22 | ||
| DK137195 | 1995-12-04 | ||
| PCT/DK1996/000266 WO1997000894A1 (en) | 1995-06-22 | 1996-06-19 | Compounds with growth hormone releasing properties |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975992D0 NO975992D0 (en) | 1997-12-19 |
| NO975992L true NO975992L (en) | 1998-02-20 |
Family
ID=26064522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975992A NO975992L (en) | 1995-06-22 | 1997-12-19 | Compounds with growth hormone releasing properties |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0833845A1 (en) |
| KR (1) | KR19990028303A (en) |
| AU (1) | AU711104B2 (en) |
| BR (1) | BR9608909A (en) |
| CA (1) | CA2224434A1 (en) |
| CZ (1) | CZ287948B6 (en) |
| HU (1) | HUP9802821A3 (en) |
| IL (1) | IL122371A0 (en) |
| NO (1) | NO975992L (en) |
| PL (1) | PL186520B1 (en) |
| TW (1) | TW458958B (en) |
| WO (1) | WO1997000894A1 (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3938797A (en) * | 1996-08-29 | 1998-03-19 | Novo Nordisk A/S | Transdermal delivery of peptides |
| EP1005484A1 (en) | 1997-06-20 | 2000-06-07 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US6127341A (en) * | 1997-06-20 | 2000-10-03 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| CA2301566A1 (en) | 1997-08-22 | 1999-03-04 | Kaken Pharmaceutical Co., Ltd. | N-acylated lipophilic amino acid derivatives |
| IL137007A0 (en) | 1998-01-16 | 2001-06-14 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| AP2000001984A0 (en) * | 1998-05-12 | 2000-12-31 | Warner Lambert Co | Combination of protein farnesyltrandferase and HMG COA reductase inhibitors and their use to treat cancer. |
| IL140044A0 (en) * | 1998-06-30 | 2002-02-10 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| US6919315B1 (en) | 1998-06-30 | 2005-07-19 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| WO2000009537A2 (en) | 1998-08-14 | 2000-02-24 | Administrators Of The Tulane Educational Fund | Compounds having growth hormone releasing activity |
| CA2362290A1 (en) | 1999-02-18 | 2000-08-24 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
| EP1159964B1 (en) | 2000-05-31 | 2009-10-28 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating gastrointestinal motility |
| EP1351924A2 (en) | 2000-12-20 | 2003-10-15 | Bristol-Myers Squibb Pharma Company | Diamines as modulators of chemokine receptor activity |
| EP1343751A2 (en) | 2000-12-20 | 2003-09-17 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| WO2007025177A2 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| CU23558A1 (en) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE |
| US8138191B2 (en) | 2007-01-11 | 2012-03-20 | Critical Outcome Technologies Inc. | Inhibitor compounds and cancer treatment methods |
| ES2604943T3 (en) | 2007-02-09 | 2017-03-10 | Ocera Therapeutics, Inc. | Ghrelin receptor macrocyclic modulators and procedures for their use |
| CA2710039C (en) | 2007-12-26 | 2018-07-03 | Critical Outcome Technologies, Inc. | Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer |
| CA2999435A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5663146A (en) * | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| CA2179597A1 (en) * | 1993-12-23 | 1995-06-29 | Nils Langeland Johansen | Compounds with growth hormone releasing properties |
| US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
-
1996
- 1996-06-19 IL IL12237196A patent/IL122371A0/en not_active IP Right Cessation
- 1996-06-19 KR KR1019970709617A patent/KR19990028303A/en not_active Application Discontinuation
- 1996-06-19 CZ CZ19974081A patent/CZ287948B6/en not_active IP Right Cessation
- 1996-06-19 WO PCT/DK1996/000266 patent/WO1997000894A1/en not_active Application Discontinuation
- 1996-06-19 CA CA002224434A patent/CA2224434A1/en not_active Abandoned
- 1996-06-19 BR BR9608909A patent/BR9608909A/en not_active Application Discontinuation
- 1996-06-19 EP EP96920742A patent/EP0833845A1/en not_active Withdrawn
- 1996-06-19 HU HU9802821A patent/HUP9802821A3/en unknown
- 1996-06-19 AU AU61882/96A patent/AU711104B2/en not_active Ceased
- 1996-06-19 PL PL96324200A patent/PL186520B1/en unknown
- 1996-06-28 TW TW085107813A patent/TW458958B/en not_active IP Right Cessation
-
1997
- 1997-12-19 NO NO975992A patent/NO975992L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11507928A (en) | 1999-07-13 |
| NO975992D0 (en) | 1997-12-19 |
| KR19990028303A (en) | 1999-04-15 |
| PL186520B1 (en) | 2004-01-30 |
| CZ408197A3 (en) | 1998-05-13 |
| TW458958B (en) | 2001-10-11 |
| CA2224434A1 (en) | 1997-01-09 |
| MX9710377A (en) | 1998-03-29 |
| PL324200A1 (en) | 1998-05-11 |
| AU6188296A (en) | 1997-01-22 |
| CZ287948B6 (en) | 2001-03-14 |
| IL122371A0 (en) | 1998-06-15 |
| HUP9802821A2 (en) | 1999-03-29 |
| HUP9802821A3 (en) | 2000-03-28 |
| EP0833845A1 (en) | 1998-04-08 |
| AU711104B2 (en) | 1999-10-07 |
| BR9608909A (en) | 1999-03-02 |
| JP4173541B2 (en) | 2008-10-29 |
| WO1997000894A1 (en) | 1997-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO973446L (en) | Compounds with growth hormone releasing properties | |
| NO975992D0 (en) | Compounds with growth hormone releasing properties | |
| HUP9802580A3 (en) | Compounds with growth hormone releasing properties | |
| DE69506086D1 (en) | COMPOSITION WITH CONTROLLED RELEASE | |
| NO982991D0 (en) | Growth hormone-sekretagoguer | |
| FI20030560A (en) | Controlled release preparation | |
| DE69533944D1 (en) | Direct seeding with Scheibensech | |
| FI973116A0 (en) | Crucible | |
| ZA985278B (en) | Compounds with growth hormone releasing properties | |
| ZA961007B (en) | Compounds with growth hormone releasing properties | |
| ZA961008B (en) | Compounds with growth hormone releasing properties | |
| FI972968A0 (en) | Methods for inhibiting growth hormone effects | |
| ZA96544B (en) | Compounds with growth hormone releasing properties | |
| ZA9610775B (en) | Compounds with growth hormone releasing properties | |
| ZA965279B (en) | Compounds with growth hormone releasing properties | |
| DE69504847D1 (en) | FERTILIZER WITH CONTROLLED RELEASE | |
| DE69636232D1 (en) | GROWTH FACTOR HTTER36 | |
| ZA9410262B (en) | Compounds with growth hormone releasing properties | |
| KR960024127U (en) | Crucible | |
| SE9203175D0 (en) | GROWTH HORMONE | |
| KR940020162U (en) | Scoop for length adjustment | |
| ZA9410261B (en) | Compounds with growth hormone releasing properties | |
| KR970001706U (en) | Integrated Manual Feeder | |
| KR940009642U (en) | Feeder spreader | |
| KR960000079U (en) | Luminous bobber |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |